138 related articles for article (PubMed ID: 34284051)
1. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
2. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.
Karamitopoulou E; Thies S; Zlobec I; Ott K; Feith M; Slotta-Huspenina J; Lordick F; Becker K; Langer R
Am J Surg Pathol; 2014 Nov; 38(11):1551-6. PubMed ID: 25140894
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
6. Clinical assessment of tumor regression grade systems in gastroesophageal adenocarcinoma following neoadjuvant chemotherapy.
Lütken C; Sheikh K; Willemoe GL; Achiam MP; Hasselby JP
Pathol Res Pract; 2021 Aug; 224():153538. PubMed ID: 34243107
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
[TBL] [Abstract][Full Text] [Related]
8. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
[TBL] [Abstract][Full Text] [Related]
9. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J
Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382
[TBL] [Abstract][Full Text] [Related]
10. Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas.
Reim D; Novotny A; Friess H; Slotta-Huspenina J; Weichert W; Ott K; Dislich B; Lorenzen S; Becker K; Langer R
J Pathol Clin Res; 2020 Oct; 6(4):263-272. PubMed ID: 32401432
[TBL] [Abstract][Full Text] [Related]
11. [Grading of tumor regression of gastrointestinal carcinomas after neoadjuvant therapy].
Liu D; Langer R
Pathologe; 2022 Feb; 43(1):51-56. PubMed ID: 34940918
[TBL] [Abstract][Full Text] [Related]
12. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
Fleischmann A; Thalmann GN; Perren A; Seiler R
Am J Surg Pathol; 2014 Mar; 38(3):325-32. PubMed ID: 24525502
[TBL] [Abstract][Full Text] [Related]
13. [Establishment and preliminary application of tissue response grading system following neoadjuvant chemotherapy].
Yang K; Zhang W; Chen X; Chen X; Liu K; Zhao L; Liu J; Wu B; Zhou Z; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1032-1038. PubMed ID: 30269324
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
[TBL] [Abstract][Full Text] [Related]
15. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.
Kinoshita O; Ichikawa D; Ichijo Y; Komatsu S; Okamoto K; Kishimoto M; Yanagisawa A; Otsuji E
World J Gastroenterol; 2015 Dec; 21(48):13500-6. PubMed ID: 26730161
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey.
Tsekrekos A; Detlefsen S; Riddell R; Conner J; Mastracci L; Sheahan K; Shetye J; Lundell L; Vieth M
Hum Pathol; 2019 Feb; 84():26-34. PubMed ID: 30217622
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship between tumor regression grade and lymph node regression grade].
Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies.
Hayashi M; Fujita T; Matsushita H
Eur J Surg Oncol; 2021 Aug; 47(8):1996-2003. PubMed ID: 33353828
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial.
Davarzani N; Hutchins GGA; West NP; Hewitt LC; Nankivell M; Cunningham D; Allum WH; Smyth E; Valeri N; Langley RE; Grabsch HI
Histopathology; 2018 Jun; 72(7):1180-1188. PubMed ID: 29465751
[TBL] [Abstract][Full Text] [Related]
20. Tumor regression grade in gastric cancer: Predictors and impact on outcome.
Blackham AU; Greenleaf E; Yamamoto M; Hollenbeak C; Gusani N; Coppola D; Pimiento JM; Wong J
J Surg Oncol; 2016 Sep; 114(4):434-9. PubMed ID: 27199217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]